H. Graf

Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients

M. Lux, M. Beckmann, P. Fasching, 2019, International journal of cancer.

Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer

M. Lux, M. Beckmann, P. Fasching, 2019, Breast Cancer Research and Treatment.

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

M. Lux, M. Beckmann, P. Fasching, 2020, Breast.

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study.

L. Zelek, A. Ballestrero, L. Fallowfield, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate – The ICE Randomized Clinical Trial

M. Untch, V. Nekljudova, J. Huober, 2023, European Journal of Cancer.